{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04705480",
            "orgStudyIdInfo": {
                "id": "20-718"
            },
            "organization": {
                "fullName": "CAMC Health System",
                "class": "OTHER"
            },
            "briefTitle": "Pregabalin vs. Gabapentin on Reducing Opioid Usage",
            "officialTitle": "Pregabalin vs. Gabapentin on Reducing Opioid Usage in Trauma Patients",
            "therapeuticArea": [
                "Other"
            ],
            "study": "pregabalin-vs-gabapentin-on-reducing-opioid-usage"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-01",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2021-04-12",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-12-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-12-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-01-08",
            "studyFirstSubmitQcDate": "2021-01-08",
            "studyFirstPostDateStruct": {
                "date": "2021-01-12",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-01-11",
            "lastUpdatePostDateStruct": {
                "date": "2023-01-12",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "John DeLuca",
                "investigatorTitle": "Trauma Surgeon",
                "investigatorAffiliation": "CAMC Health System"
            },
            "leadSponsor": {
                "name": "CAMC Health System",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "This is a single-center, randomized, open-label, Phase 4 clinical trial investigating the efficacy of multiple-dose administrations of Pregabalin or Gabapentin in combination with traditional opioid pain medications to decrease the amount of opioid pain medication usage in single-system orthopedic trauma patients."
        },
        "conditionsModule": {
            "conditions": [
                "Analgesics",
                "Gabapentin",
                "Injuries",
                "Narcotics",
                "Pain",
                "Trauma"
            ],
            "keywords": [
                "Pregabalin , ,",
                "Gabapentin",
                "Opioid Pain Medication Use",
                "Trauma",
                "Opioid Usage Reduction"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE4"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 210,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Pregabalin",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: Pregabalin 50mg"
                    ]
                },
                {
                    "label": "Gabapentin",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: Gabapentin 300mg"
                    ]
                },
                {
                    "label": "Neither Pregabalin nor Gabapentin",
                    "type": "ACTIVE_COMPARATOR",
                    "interventionNames": [
                        "Drug: Neither Pregabalin nor Gabapentin"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Pregabalin 50mg",
                    "description": "Patients will receive 50 mg every 8 hours without dose titration. Patients with CrCl \\< 60mL/min will receive same dose given q12 hours. The q12 hour regimen may be increased to q8 hours if CrCl increases above 60mL/min during the 7 days study period or until discharge (if \\< 7 days post-enrollment).",
                    "armGroupLabels": [
                        "Pregabalin"
                    ],
                    "otherNames": [
                        "Lyrica"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Gabapentin 300mg",
                    "description": "Patients will receive 300 mg PO every 8 hours without dose titration. Patients with CrCl \\< 60mL/min will receive same dose given q12 hours. The q12 hour regimen may be increased to q8 hours if CrCl increases above 60mL/min during the 7 days study period or until discharge (if \\< 7 days post-enrollment).",
                    "armGroupLabels": [
                        "Gabapentin"
                    ],
                    "otherNames": [
                        "Neurontin"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Neither Pregabalin nor Gabapentin",
                    "description": "Patients will receive neither Pregabalin nor Gabapentin.",
                    "armGroupLabels": [
                        "Neither Pregabalin nor Gabapentin"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Reduction in opioid usage",
                    "description": "To determine if adding multiple doses of pregabalin or gabapentin upon admission will reduce opioid usage administered in oral Morphine Milligram Equivalents in trauma patients.",
                    "timeFrame": "First 7 days post-enrollment or until discharge, if discharge < 7 days post-enrollment"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Incentive spirometry values",
                    "description": "To compare the change in documented incentive spirometry values (liters) from morning physical assessment among patients in each of the study groups who have at least 1 rib fracture.",
                    "timeFrame": "First 7 days post-enrollment or until discharge, if discharge < 7 days post-enrollment"
                },
                {
                    "measure": "Rate of intubation",
                    "description": "To compare the proportion of patients requiring intubation among the study groups.",
                    "timeFrame": "First 7 days post-enrollment or until discharge, if discharge < 7 days post-enrollment"
                },
                {
                    "measure": "Pain control",
                    "description": "To assess effectiveness of pain control in each arm based on the average Numeric Pain Rating Scale score per 24 hours. This scale is a 10 point numeric scale that ranges from 0 that represents \"no pain\" to 10 which indicates the \"worst pain imaginable.\"",
                    "timeFrame": "First 7 days post-enrolment or until discharge, if discharge < 7 days post-enrollment"
                },
                {
                    "measure": "Hospital length of stay",
                    "description": "To evaluate the differences among the study arms with respect to hospital length of stay (days).",
                    "timeFrame": "First 7 days post-enrollment or until discharge, if discharge < 7 days post-enrollment"
                },
                {
                    "measure": "Rate of unplanned ICU admission",
                    "description": "To evaluate the differences among the study arms with respect to proportion of unplanned ICU admission.",
                    "timeFrame": "First 7 days post-enrollment or until discharge, if discharge < 7 days post-enrollment"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Nurse Practitioner service admissions\n2. 18 years of age or older\n3. Patients enrolled within 36 hours of admission\n4. Anticipated duration of hospitalization \\> 24 hours from time of consent\n5. Active order(s) for opioids in place at the time of enrollment\n\nExclusion Criteria:\n\n1. Clinician discretion based on patient care management\n2. Intubated patients\n3. Patients with epidural\n4. Patients with pregabalin/gabapentin as home medications\n5. Patients receiving pregabalin/gabapentin upon admission\n6. Traumatic brain injury patients\n7. CrCl\\<30ml/min or on HD\n8. Unable to take enteral medications\n9. On Patient Controlled Analgesia (PCA)\n10. Patients with complicated wound closure\n11. History of epilepsy\n12. Documented history of substance use disorder",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "John A DeLuca, MD",
                    "role": "CONTACT",
                    "phone": "3043887278",
                    "email": "john.deluca@camc.org"
                }
            ],
            "locations": [
                {
                    "facility": "Charleston Area Medical Center\"s Level 1 Trauma Center",
                    "status": "RECRUITING",
                    "city": "Charleston",
                    "state": "West Virginia",
                    "zip": "25301",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Damayanti Samanta, MS",
                            "role": "CONTACT",
                            "phone": "304-388-7808",
                            "email": "damayanti.samanta@camc.org"
                        },
                        {
                            "name": "Nancy Duvall, RN-BC, MS",
                            "role": "CONTACT",
                            "phone": "3043883653",
                            "email": "nancy.duvall@camc.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.34982,
                        "lon": -81.63262
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000014947",
                    "term": "Wounds and Injuries"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M17685",
                    "name": "Wounds and Injuries",
                    "asFound": "Trauma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M13066",
                    "name": "Pain",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC26",
                    "name": "Wounds and Injuries"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000069583",
                    "term": "Pregabalin"
                },
                {
                    "id": "D000077206",
                    "term": "Gabapentin"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000700",
                    "term": "Analgesics"
                },
                {
                    "id": "D000018689",
                    "term": "Sensory System Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000000927",
                    "term": "Anticonvulsants"
                },
                {
                    "id": "D000002121",
                    "term": "Calcium Channel Blockers"
                },
                {
                    "id": "D000049990",
                    "term": "Membrane Transport Modulators"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000077264",
                    "term": "Calcium-Regulating Hormones and Agents"
                },
                {
                    "id": "D000014151",
                    "term": "Anti-Anxiety Agents"
                },
                {
                    "id": "D000014149",
                    "term": "Tranquilizing Agents"
                },
                {
                    "id": "D000002492",
                    "term": "Central Nervous System Depressants"
                },
                {
                    "id": "D000011619",
                    "term": "Psychotropic Drugs"
                },
                {
                    "id": "D000018691",
                    "term": "Excitatory Amino Acid Antagonists"
                },
                {
                    "id": "D000018683",
                    "term": "Excitatory Amino Acid Agents"
                },
                {
                    "id": "D000018377",
                    "term": "Neurotransmitter Agents"
                },
                {
                    "id": "D000018692",
                    "term": "Antimanic Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M4033",
                    "name": "Analgesics, Opioid",
                    "relevance": "LOW"
                },
                {
                    "id": "M476",
                    "name": "Pregabalin",
                    "asFound": "How",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4032",
                    "name": "Analgesics",
                    "relevance": "LOW"
                },
                {
                    "id": "M1694",
                    "name": "Gabapentin",
                    "asFound": "Guidance",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4246",
                    "name": "Anticonvulsants",
                    "relevance": "LOW"
                },
                {
                    "id": "M5384",
                    "name": "Calcium Channel Blockers",
                    "relevance": "LOW"
                },
                {
                    "id": "M5381",
                    "name": "Calcium",
                    "relevance": "LOW"
                },
                {
                    "id": "M5398",
                    "name": "Calcium, Dietary",
                    "relevance": "LOW"
                },
                {
                    "id": "M9789",
                    "name": "Hormones",
                    "relevance": "LOW"
                },
                {
                    "id": "M16905",
                    "name": "Anti-Anxiety Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M14474",
                    "name": "Psychotropic Drugs",
                    "relevance": "LOW"
                },
                {
                    "id": "M20771",
                    "name": "Excitatory Amino Acid Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M20504",
                    "name": "Neurotransmitter Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Analg",
                    "name": "Analgesics"
                },
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "ChanBlk",
                    "name": "Channel Blockers"
                },
                {
                    "abbrev": "AntiConv",
                    "name": "Anticonvulsants"
                },
                {
                    "abbrev": "PsychDr",
                    "name": "Psychotropic Drugs"
                },
                {
                    "abbrev": "BDCA",
                    "name": "Bone Density Conservation Agents"
                }
            ]
        }
    },
    "hasResults": false
}